IGF1 and glioma: On the contrary, the anti-tumorigenic and anti-angiogenetic functions of IGFBP-4 in glioma cells depend to its ability to induce dibutyryl cyclic AMP (dB-cAMP) that antagonize the VEGFs action in an IGF-independent manner (59).